SGLT2 inhibitors and incretin agents: Associations with alanine aminotransferase activity in type 2 diabetes. [electronic resource]
Producer: 20190305Description: 493-499 p. digitalISSN:- 1878-1780
- Aged
- Aged, 80 and over
- Alanine Transaminase -- blood
- Benzhydryl Compounds -- therapeutic use
- Canada
- Canagliflozin -- therapeutic use
- Diabetes Mellitus, Type 2 -- blood
- Female
- Glucosides -- therapeutic use
- Humans
- Hypoglycemic Agents -- therapeutic use
- Incretins -- therapeutic use
- Liraglutide -- therapeutic use
- Male
- Middle Aged
- Registries
- Retrospective Studies
- Sitagliptin Phosphate -- therapeutic use
- Sodium-Glucose Transporter 2 Inhibitors -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.